Vibativ Lyophilisate For Solution For Injection 250Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Vibativ: Lyophilisate for solution for injection (250mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

TELAVANCIN (TEL a van sin) is an antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

In-Depth Information
Select a Medication

Vibativ 250mg Powder for Injection

NDC: 004693525
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Skin And Skin Structure Infections, Nosocomial Pneumonia

Sometimes used for but not FDA approved for the following conditions:
Bacteremia

Storage Information
Store original packages in refrigerator (35 to 46 degrees F), excursions permitted up to 77 degrees F
Avoid excessive heat (above 104 degrees F)
Vibativ 250mg Powder for Injection

Reported Side Effects for Vibativ 250mg Powder for Injection

Kidney Failure Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Long Qt Syndrome Incidence:
1.0%*
Severity: MODERATE
Onset: RAPID
Stomach Pain Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
3.0%*
Severity: MODERATE
Onset: EARLY
Chills Incidence:
4.0%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
5.0-27.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
5.0-14.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
6.0%*
Severity: MILD
Onset: RAPID
Loose Stools Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
33.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Vibativ

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5